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Background: Biological networks are important for elucidating disease etiology due to their ability to model
complex high dimensional data and biological systems. Proteomics provides a critical data source for such models,
but currently lacks robust de novo methods for network construction, which could bring important insights in
systems biology.
Results: We have evaluated the construction of network models using methods derived from weighted gene
co-expression network analysis (WGCNA). We show that approximately scale-free peptide networks, composed of
statistically significant modules, are feasible and biologically meaningful using two mouse lung experiments and
one human plasma experiment. Within each network, peptides derived from the same protein are shown to have a
statistically higher topological overlap and concordance in abundance, which is potentially important for inferring
protein abundance. The module representatives, called eigenpeptides, correlate significantly with biological
phenotypes. Furthermore, within modules, we find significant enrichment for biological function and known
interactions (gene ontology and protein-protein interactions).
Conclusions: Biological networks are important tools in the analysis of complex systems. In this paper we evaluate
the application of weighted co-expression network analysis to quantitative proteomics data. Protein co-expression
networks allow novel approaches for biological interpretation, quality control, inference of protein abundance, a
framework for potentially resolving degenerate peptide-protein mappings, and a biomarker signature discovery.
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Systems biology embraces the complexity found in bio-
logical networks by taking a holistic view of the cell
[1,2]. As systems biology moves forward, models making
use of quantitative proteomic data will become increas-
ingly necessary since this information is not accessible
using other analytical methods [3,4].
Large-scale quantitative proteomics, however, is still de-
veloping and can be challenging and complex in practice
[5,6]. In order to boost throughput and ease computation,
tag-based approaches are used [7]. Briefly, proteins are
digested enzymatically, producing a multitude of peptide
fragments. Using liquid chromatography coupled to mass
spectroscopy (referred to as LC-MS), the digested mixture
is quantified, resulting in a set of features containing both
mass and net elution time measurements. Peptides are* Correspondence: gibbsd@ohsu.edu
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reproduction in any medium, provided the oridentified by mapping features to entries in an accurate
mass and time tag (AMT) database. Tag databases are
constructed using pooled samples processed on a tandem
MS/MS platform [8].
Currently, a majority of protein networks are cons-
tructed using protein-protein interaction (PPI) data-
bases. However, manually curated PPI databases are
regularly revised as our understanding of biology grows.
PPI databases are typically heterogeneous, containing
different experiment types and model organisms, leading
to sparse annotation and a lack of experimental con-
cordance [9]. In addition, interaction temporality and
contextual information is lacking. Coverage, selection
bias, and detection bias all remain problems [9,10].
De novo approaches based on observed data offer an
alternative under which prior knowledge of protein
interaction is eliminated and replaced by direct measure-
ments of abundance. In this paper, we evaluate a novel
approach to proteomic network analysis that is applic-
able to peptide and protein level data (see Figure 1). Bytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Detail of the peptide network. (A) The peptide network is decomposed into a set of subnetworks or modules. Module members, the
peptide nodes, are more connected to peptides within the module, than across modules. (B) Singular value decomposition on the peptide
abundance module matrix produces module summaries called eigenpeptides. Module prioritization is accomplished by correlating the
eigenpeptide with sample phenotypes. By correlating peptides to the module summary, relative peptide importance is determined. (C) Taking
peptides that map to a given protein defines a protein subnetwork. Peptides tend to be strongly connected within a protein subnetwork.
(D) Difficulties arise when peptide nodes map to multiple proteins, rendering them degenerate.
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network analysis (WGCNA) [11,12], we show that un-
biased de novo protein co-expression networks can be
constructed and used for determining potential bio-
markers, functional module prediction, and the discovery
of important elements of human disease. We evaluate
these methods utilizing data from two mouse infectious
disease studies for SARS and Influenza, as well as a hu-
man population proteomics study for sarcopenia.
Methods
Mouse and human proteomic data sources
Three quantitative LC-MS data sets including both human
and mouse disease studies were used. The Thermo Electron
Exactive platform was used to generate data. The Pacific
Northwest National Labs (PNNL, http://omics.pnl.gov) de-
veloped the Accurate Mass and Time (AMT) tag databases.
VIPER (v3.48) is used to align individual samples and iden-
tify peptides using an AMT database [13]. Identifications
have confidence metrics: the probability for a correct
match, the STAC score, and the probability for a unique
database match, the uniqueness probability (UP) [14].
Peptides with STAC scores > 0 and UP > 0 were used. Pep-
tide abundances were normalized by total ion count per
sample and log10 scaled. Missing data are encounteredwhen peptides are identified in a subset of samples.
“Missingness filtration” involves removing any peptide with
greater than X% missing data across samples. In this case,
peptides with greater than 10% missing data were removed.
The infectious disease data came from the NIAID
Systems Virology project (publically available data is
found at http://www.systemsvirology.org). We utilized
both longitudinal SARS-CoV and influenza mouse stud-
ies. These data are generated using C57BL/6J mice ex-
posed to either a mouse adapted SARS-CoV (MA-15) or
avian influenza virus (A/Vietnam/1203/2004 (H5N1,
VN1203)) [15,16]. Measurements took place on post in-
fection days 1, 2, 4 and 7.
SARS control samples include three technical replicates
per day. Infected samples are five technical replicates with
viral dosages of 102, 103, 104, and 105 PFU per day.
Abundance measurements for 16,890 peptides mapping
to 3,277 proteins were recorded. After missingness filtra-
tion, 2,008 peptides mapping to 707 proteins remained.
352 proteins were associated with a single peptide, while
355 proteins had two or more peptides associated.
Influenza control samples include three technical rep-
licates per day. Infected samples include five technical
replicates with dosages of 102, 103, and 104 PFU per day.
Abundances for 10,285 peptides mapping to 2,661
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peptides associated with 493 proteins remained. 274 pro-
teins were associated with a single peptide, while 219
proteins had at least 2 peptides associated.
The human proteomics data (currently unpublished)
comes from a sub-cohort of participants selected from a
large (N=6000) longitudinal study of musculoskeletal
health in older (≥ 65 years) men (from the Osteoporotic
Fractures in Men (MrOS) Study) [17,18]. The protocol
was approved by the local institutional review boards. All
participants provided written informed consent. The sub-
cohort is focused on the sarcopenia phenotype, which is
related to loss of lean mass and muscle performance [19].
A subset of 68 samples from two phenotyped groups
(sarcopenic (N=38) and non-sarcopenic (N=30)) based on
lean mass and leg power are used. Abundances for 10,679
peptides mapping to 1,868 proteins were recorded. After
missingness filtration, 2,845 peptides mapping to 685 pro-
teins remained. 505 proteins were associated with a single
peptide, and 180 were associated with at least two
peptides.
Protein co-expression network construction
Protein co-expression networks contain nodes repre-
senting peptides connected with edges weighted by simi-
larity in abundance profile. Edge weights are calculated
using peptide intensity measurements. Although not al-
ways representative of absolute abundance, intensity is
frequently used to track relative peptide abundance and
to infer protein abundance [20]. In this work, we did not
attempt to rectify situations where proteins were repre-
sented by a single peptide or where degenerate peptides
mapped to multiple proteins. See Additional file 1 for a
description of the software used in this work.
Construction of the network follows the WGCNA
method [21-24]. Pearson’s correlations are computed
pairwise between all peptides, retaining the sign as in
Mason et al., resulting in a signed similarity matrix [25].
According to the scale-free criterion, a power (beta) is se-
lected that transforms the distribution of node degrees in
the similarity matrix to log-linear, producing the appropri-
ate adjacency matrix. Topological overlap is a similarity
metric that incorporates information from neighboring
nodes, making it robust to noisy correlations. The TOM is
computed as TOMij = (lij + aij) / [min (ki, kj) + 1 - aij]
where lij is defined as the dot product on row i and col-
umn j in adjacency matrix [a] and ki (the connectivity) is
the summation of row i in adjacency matrix [a]. Modules,
or subnetworks, are composed of strongly connected pep-
tides. Modules are discovered by hierarchical clustering of
the distance matrix, 1-TOM, using the “average” agglom-
eration method, followed by branch cutting with the dy-
namic hybrid treecut algorithm [21]. The following
parameters were used after visualization and exploratoryanalysis: deepSplit = 2, minModuleSize = 30, merge-
Threshold = 0.1.
Calculating module significance using permutation
testing
Similar to Iancu et al. [26,27], module significance was
examined using permutation testing. Empirical p-values
are computed by comparing the mean topological over-
lap of peptides within a module to a similarly sized
random peptide sample. These samples are taken from
the total set of peptides used in the network. For a given
module with size n, mean edge weights are computed. For
a number of trials, t, a sample of peptides is drawn with
size equal to n, and the mean edge weight computed. If
this value is equal to, or higher than the observed module
mean, a count is incremented. The p-value is equal to
(counts/t). In this work 10,000 random samples were
drawn.
Summarizing modules with eigenpeptides
After assigning peptides to modules, an aggregate mod-
ule signature is computed. The first right-singular vector,
or eigenpeptide, is computed from a singular value
decomposition of the standardized abundance module
matrix. The eigenpeptide has length equal to the number
of samples. This vector acts as an overall summary of
the module. Modules can be prioritized according to
correlations between the eigenpeptide and biological
phenotypes. Additionally, the relative centrality, or
“importance” of any given peptide within a module is
found by computing a Pearson’s correlation to the
eigenpeptide (called the Kme) [28,29]. Peptides with a
strong correlation to the eigenpeptide are said to be
more central, and important within the module, allowing
prioritization on peptides.
Describing concordance of peptides within modules
Concordance among a set of peptides relates to the
shared sign of the slope when regressed against a given
variable such as time or infection status. Our approach
to this problem involves constructing protein sub-
networks, initially as “all-to-all” networks. After applying
a topological overlap threshold, edges start to fall away.
This results in a disjoint set of connected components.
Two methods were used to examine whether concord-
ant peptides are connected in the network. First, a linear
model is constructed for each peptide using a reference
variable such as time or a phenotypic trait. Peptides are
classified as increasing (+1), decreasing (−1), or no-slope
(0) depending on the adjusted p-value. If a connected sub-
graph contains both increasing and decreasing peptides, it
is considered a discordant component (see Figure 2).
Alternatively, the expression fold change (infected vs.
non-infected) of peptides can be compared within a
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of 1.5 was used to define peptides as up or down regu-
lated. If both up and down labeled peptides mapped to a
protein, then the protein was counted as discordant.
Testing for strong peptide connectivity by protein
Similar to testing for module significance, the connectivity
among peptides mapping to a given protein can be tested
by permutation. For each protein with greater than two
peptides, the pairwise topological overlaps are averaged.
Then for a set number of trials (10,000), the same number
of peptides is randomly sampled from all peptides in the
network, and the mean pair wise topological overlap
recorded. The empirical p-value is taken as the number of
times the random sample has values equal or greater than
the observed case divided by the number of trials. This
test can also be applied using correlations between the
peptides.
Protein-protein interaction enrichment within modules
Co-expression modules are thought to reflect, to some de-
gree, true protein interactions. To examine this, we com-
pare the contents of modules with known PPIs. As
previously done, permutation testing was used to deter-
mine whether a significant amount of PPI edges exist
within a module. Within each module, peptides with weak
connections to the module eigenpeptide were removed
(Kme < 0.333). Centrality filtration is performed to focus
the analysis on peptides associated with overall module
function. The remaining peptides are mapped to proteins.
Proteins with any number of mapping peptides are in-
cluded. The number of observed PPIs within a module is
recorded and compared to the number of PPIs in a ran-
dom module for a set number of trials. P-values are com-
puted using permutation testing as before. The PPI
databases HPRD [30] and MPPI [31] were used for human
and mouse data respectively.Figure 2 Utility of de novo network inference in resolving peptide lev
topological overlap show correlated clusters. Taken together, some protein
such as time, some peptides are increasing in abundance and other decrea
peptides were used. A protein sub-network is constructed by taking associ
specified upper quantile (e.g. the upper 20% of all topological overlaps for
the number of connected components with discordant peptides dramatica
can be guided by network topology.Pathway enrichment within modules
After PPI enrichment tests, significant sets of proteins
were collected by module. Querying KEGG [32,33], using
the R package KEGGSOAP [34], with these proteins pro-
vided a list of potential pathways to investigate by module.
For each pathway returned, a hypergeometric test was
performed using significant PPIs from the module and
other proteins taking part in the pathway. The universe is
defined as the subset of proteins in the mass tag database
with known roles in KEGG pathways. P-values are ad-
justed using the Benjamini and Yekutieli method [35].
Gene ontology functional enrichment within modules
Functional enrichment on modules was computed using
the R package GOstats [36]. Peptides are mapped to pro-
teins and counted once in any module. The universe is
defined as all proteins found in the AMT mass tag data-
base (similar to microarray studies). Annotation data-
bases “org.Mm.eg.db” and “org.Hs.eg.db” (Bioconductor
2.8) are used for mouse and human annotations. Condi-
tional hypergeometric testing is used to account for cor-
related GO terms.
Results and discussion
Peptide networks were approximately scale-free
Scale-free network topologies have node degree distribu-
tions following the power law [37,38]. There is a continu-
ous range of node degrees, with the fewest nodes having
the greatest number of connections [37,38]. We found
that peptide networks share this topology (Figure 3) and
have biologically informative graph properties similar to
those found in gene co-expression networks (See descrip-
tive network statistics in Table 1).
With regard to distinct and significant modules, the
SARS network contained 14 modules ranging from 65 to
369 peptides, with a mean size of 133.9 peptides. The In-
fluenza network contained 6 modules, with sizes rangingel discordance. Protein sub-networks constructed using peptide
s show conflicts between constituent peptides, where given a variable
sing (A). To examine this, only proteins with uniquely mapping
ated peptides, and keeping only edges with topological overlaps in a
the protein). In all three data sources, as the edge threshold is raised,
lly decreases (B, C). This suggests that inference of protein abundance
Figure 3 Protein co-expression networks are shown to be approximately scale-free. As the soft thresholding power, β, grows, the resulting
adjacency matrix increasingly fits the scale-free model. This trend is robust to missing data, shown here with networks constructed using signed
similarity matrices. Subsets of peptide data were taken to eliminate missing data (dark lines). Then, incrementally, additional peptides were
included containing between one to ten missing data points, shown here with lighter, broken lines. For network analysis, it is strongly in our
interest to incorporate peptides with missing data, since it increases the proteome coverage without weakening the model.
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tides. The sarcopenia network contained 19 modules
ranging in size from 36 to 477 peptides, with a mean size
of 142.25 peptides. An initial examination indicates that
low to moderate levels of missing data did not negatively
impact the model fit (Figure 3). Importantly, we note
that all of the identified de-novo modules have signifi-
cant connectivity with the exception of the sarcopenia
network, which contained one module without signifi-
cant connectivity (p-value 0.33).Significant modules were correlated with phenotype
Using module summaries (i.e., eigenpeptide), correlation
with biological phenotypes can guide the discovery ofTable 1 Co-expression network construction methods are app
Data Peptides Proteins Power
Sarcopenia 2845 685 15
SARS 2008 707 16
Influenza 989 493 15
Power is the parameter used to scale the adjacency matrix. R2 and Slope describe th
adjacency matrix.biomarkers and aid in prioritization of modules for val-
idation and perturbation experiments (see Figure 4).
In the SARS network, strong correlations with disease-
related pathological features were observed, including dif-
fuse alveolar damage, tissue inflammation, and alveoli
parenchyma pneumonia (Figure 5). The strongest correla-
tions were found with time (module 3, Pearson correlation
0.8, p-value 1e-22) potentially relating to progression of
infection.
The influenza network showed strong correlations with
average weight loss, an important indicator of infection se-
verity. Two modules showed positive correlation (p-values
2e-10 and 2e-6), and two modules showed negative correl-
ation (p-values 8e-10 and 2e-15).
The sarcopenia network showed the weakest correla-
tions with sample phenotypes. Several modules correlatelicable to proteomics
R^2 Slope Mean K Modules
0.81 −1.55 25.22 19
0.76 −1.67 10.8 14
0.82 −1.31 7.00 6
e scale-free topology fit. Definition of mean K: network connectivity using the
Figure 4 Correlation with biological phenotypes can aid in prioritization of modules and proteins. In modules where the eigenpeptide is
strongly correlated with a biological phenotype, an upward trend is observed between the Kme of a peptide and the correlation with the given
phenotype. An illustration from the Influenza data is shown. This demonstrates structural order within the module. After sorting along these
dimensions, top peptides suggest further experiments.
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method did not completely remove systematic effects.
This finding guided the re-evaluation of data processing
and motivated new methods in normalization, which is in
preparation by Baraff et al.Peptide modules had significant protein-level
connectivity
Given a complex biological mixture, a significant problem
in quantitative proteomics remains in confidently identify-
ing the protein component. This problem is made worse
by the existence of degenerate peptides, which can lead to
multiple solutions for peptide to protein mapping. We
find that the connectivity of a protein’s constituent pep-
tides is far from random. This is potentially useful for
resolving cases of degenerate peptide mapping, increasing
confidence in protein identification.
Topological overlap can be utilized with a threshold to
identify high confidence edges between peptides. Upon
examination, we found that with a topological overlap
threshold of 80% (keeping only edges in the top 20% of all
weights), the majority of proteins remained connected
(Sarcopenia 84%, SARS 72%, influenza 63%).To test for significant protein connectivity, we com-
pared the mean topological overlap between constituent
peptides and similar numbers of randomly selected pep-
tides. In this evaluation of mean protein connectivities
and random connectivities, we found significant connec-
tions between constituent peptides compared to those
seen at random (Table 2). This suggests that the network
structure should be helpful in resolving degenerate map-
pings by comparing network graphs and connectivities
for alternative peptide-to-protein attributions.Strongly connected peptides were concordant
Discordance observed among related peptides (i.e., those
from the same protein) might reflect the activities of pro-
teins with differing post-translational modifications or dif-
ferent isoforms. First we assessed the relationship between
connectivity and peptide discordance with respect to
abundance over time (Figure 6). In the influenza data set,
as the edge weight threshold increases, the number of dis-
cordant edges quickly drops to zero far before the linear
trend of concordant edges.
Examining discordance in the fold change of peptide
expression, and using proteins with unique peptide map-
pings, 48 of 218 proteins in the SARS data were
Figure 5 The de novo modules (represented by module eigenpeptide, ME), are highly correlated to pathologically associated
phenotypes. An illustration from the SARS dataset is shown. Clear patterns emerge showing positive and negative correlation clusters. As
expected, related phenotypes such as airspace inflammation, interstitial septum inflammation, and diffuse alveolar damage tend to be correlated
in the same direction showing an overarching biological process at work. Label Key: Alv.Par.Pneumonia: alveolar parenchyma pneumonia, DAD:
diffuse alveolar damage, OverallTotalScore: cumulative score calculated by a pathologist.
Table 2 Network topology may be useful for resolving
degenerate peptide mappings
Data Peptides Proteins Mean TO RandomTO p-value
Sarcopenia 2845 685 0.089 0.004 2.09e-14
SARS 2008 707 0.025 0.004 2.2e-16
Influenza 989 493 0.028 0.005 8.99e-16
Results from a two-sample t-test between topological overlap (TO) of peptides
derived from the same protein versus peptides selected at random. This result
statistically shows that the connectivity for a protein’s constituent peptides is
far from random. Network topology may be useful for resolving cases of
degenerate peptide mapping, increasing confidence in protein identification.
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old of 0.8 (as above), the number of discordant compo-
nents dropped to 24, and with a threshold of 0.9
dropped to 12. In the sarcopenia network, peptides that
were modeled against leg strength provided the most
discordant proteins, resulting in 11 of 139 discordant
proteins. After applying the topological overlap thresh-
olds of 0.8 and 0.9, these dropped to 4 and 3 respect-
ively. In influenza, there were 15 (out of 115 proteins)
classified as discordant; this reduced to 7 and 3 respect-
ively after applying the 0.8 and 0.9 thresholds. It appears
that edge strength is informative with respect to con-
cordance among constituent peptides for any given
Figure 6 Strongly connected peptides are concordant when regressed against time. An illustration from the influenza dataset is shown. A
protein sub-network consists of peptides mapping to a given protein, forming a all-to-all network with weighted edges. Applying an edge
threshold decreases the number of “strong” peptide connections. An edge is counted as concordant if the two connected peptides have
significant slopes in the same direction after linear regression against infection day. The discordant edges are clearly differentiated by
edge thresholding.
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ence and quantification.
Modules had significant enrichment for known PPI
interactions
De novo co-expression modules are thought to be useful
for detecting new interactions and/or functional pathway
members. We first evaluate, however, whether the de
novo modules are enriched for known interactions to
aid in assessing the utility of this approach. Using the
HURD and MPPI protein-protein interaction databases,
significant interactions were identified in all three exper-
iments. After adjusting for multiple testing, the influenza
network had 5/6 modules with significant PPI enrich-
ment, the SARS network had 12/14 modules signifi-
cantly enriched and the MrOS network had 10/19. Some
modules overlapped in terms of mapped proteins which
is typically the result of highly similar or related protein
sequences, such as sets of histones.
We then examined whether modules with significant
PPIs were also enriched for known pathways, similar to
what has been seen in de-novo gene expression studies.
For the influenza modules with significant PPIenrichment, we examined known pathways in the KEGG
database. When defining the universe (or background for
comparison) as all proteins contained in the mass tag
database (5,521 proteins), a range of significant pathways
were found, including “regulation of actin cytoskeleton”
(mmu:04810), the “tight junctions” pathway (mmu:04530),
and the “antigen presentation and processing” pathway
(mmu:04612). However, if the universe is restricted to only
those proteins with KEGG annotations (2,539 proteins),
the antigen presentation pathway alone remained signifi-
cant in two modules. These pathways are important in the
pathological progression of influenza, highlighting the
relationship between network structure and biology. Iden-
tification of enriched pathways in these unbiased modules
could potentially aid discovery of novel interactions or
pathway members.
Modules had significant gene ontology functional
enrichment
Given the significant numbers of PPI interactions, mod-
ules may have overarching functional organization. To
study this, Gene Ontology enrichment, by module, was
evaluated using the GOstats package [36]. All three data
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cant Bonferroni adjusted p-values (Additional file 2:
Table S1). In the SARS and influenza networks, enrich-
ment for biological processes such as DNA packaging,
cellular component assembly, and cellular complex
assembly was observed. The sarcopenia network mod-
ules also showed significant functional enrichment, in-
cluding immune response and blood processes. This
further reiterates the non-random, biological compos-
ition of these modules and provides support for the use
of this approach to network inference in proteomics. We
note that this framework is generalizable to many data
types and is not limited to proteomics.Conclusions
We have demonstrated the feasibility of constructing de
novo peptide co-expression networks. We show that these
networks have a biologically meaningful and approxi-
mately scale-free topology and contain statistically signifi-
cant modules. We also noted that the network structure
and connectivity of the modules are potentially useful for
resolution of degenerate peptides and inference of protein
abundance. Across three distinct experiments, we have il-
lustrated how module summaries significantly correlate
with clinically relevant phenotypes. In addition, we have
shown how de novo modules show significant enrichment
for known PPI and biological function. Peptides can be
ranked according to their module centrality and relation-
ship to phenotypic traits, allowing researchers to prioritize
targets for further research. Finally, modules can provide a
natural aggregate representation for composite biomarker
discovery.Additional files
Additional file 1: The ProCoNA Software Supplemental (added to
Bioconductor), describes the R package developed as part of this
work, along with the relevant functions and descriptions of their
use.
Additional file 2: Table S1. Protein Co-expression Network Analysis
(ProCoNA) GO enrichment summary results and examples. These tables
give in-depth examples of the results from gene ontology enrichment for
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